NIH-funded research NIH-funded research

Creating engineered bacteria for new therapies

Official title: Engineering bacterial multicellular structures for therapeutic applications

Funded at Univ of Maryland, College Park · NIH-11020130 · Data updated 2026-11-12

This study is exploring how to create special clusters of friendly bacteria that can stick to certain parts of the body and help with treatments like cavity prevention, vaginal health, and wound care, making them more effective and long-lasting.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of Maryland, College Park
NIH-funded
Lab location1 site (College Park, United States)
Project startMay 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$382,136
NIH project number1R35GM157144-01
Project IDNIH-11020130 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals seeking new treatments for conditions related to bacterial infections or tissue healing.

Less likely to help

Patients with conditions that do not involve bacterial interactions or require non-bacterial therapies may not benefit from this research.

What this research studies

This research focuses on designing programmable bioengineered multicellular structures (ProBioMS) using probiotic bacteria. By genetically modifying these bacteria to enhance their ability to self-assemble, the goal is to create larger structures that can effectively adhere to specific body tissues and provide therapeutic benefits. These engineered bacteria could be used in various applications, such as anticavity treatments, vaginal creams, and wound dressings, by ensuring they remain viable and effective over time. The research aims to optimize the size and interaction of these bacterial structures to improve their therapeutic potential.

Why it matters

Potential benefit: If successful, this research could lead to innovative probiotic-based therapies that improve treatment outcomes for various health conditions.

How similar studies have gone: Previous research has shown promise in using engineered probiotics for therapeutic applications, indicating potential success for this approach.

Where this research is happening

  • Univ of Maryland, College Park
    College Park, United States
    Active

Researchers

  • Principal investigator: Molinari, Sara — Univ of Maryland, College Park
  • Study coordinator: Molinari, Sara

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.